Hybrid operating room for advanced non-small cell lung cancer such as T4-NSCLC
National Center for Respiratory MedicinePeer-Reviewed Publication
The management of non-small cell lung cancer (NSCLC) has recently evolved and is highly dependent on its staging, molecular characteristics, and patient condition. The preoperative stage of NSCLC remains the primary factor in determining treatment and overall prognosis.
Thoracic surgery has made enormous progress in the last decade thanks to minimally invasive procedures, intra-operative imaging, artificial intelligence (AI), and technological evolution, moving towards precision surgery.
In this new scenario, it is appropriate to evaluate the potential resectability of T4-NSCLC that invades the thoracic aorta (T4invAo) and reasonable to plan radical surgery in these patients.
Endovascular treatment is the gold standard for managing thoracic aortic pathology. This minimally invasive approach reduces perioperative morbidity and mortality rates compared to traditional open surgery. The hybrid operating room (HOR) plays a fundamental role in this context, allowing for the best technical strategy in a “one-stop” procedure.
- Journal
- Journal of Thoracic Disease